Some of the biggest coronavirus vaccine manufacturers say they are not selling shots to provincial governments because they only want to deal with one contract per country at a time.
This comes as premiers in Alberta and Manitoba join arms in calling for a Plan B interprovincial task force to secure their own vaccine supplies following delays in deliveries to the federal government, and a lack of clarity from the federal government around the terms of those crucial contracts.
During the pandemic, we are committed to bringing this vaccine to help meet the public health need and only plan to sell the vaccine to the Government of Canada, said Christina Antoniou, director of corporate affairs for Pfizer.
The federal governments National Operations Centre is responsible for distributing the vaccine to each of the provinces, and we are working closely with them to support their efforts.
Story continues below advertisement
In order the (sic) optimally address the pandemic situation worldwide, Pfizer decided to have one agreement per country, Antoniou added.
The idea was to limit the number of contractual agreements during the pandemic phase. As such, we have one contract for Canada. That will be the case until we have delivered on the full contract.
Global News reached out to Pfizer, Moderna, AstraZeneca and Johnson & Johnson following comments by Manitoba Premier Brian Pallister during an interview with Global News last week.
Pallister said the federal governments contracts with those major vaccine suppliers forbid those companies from selling vaccines to the provinces in separate deals.
Theyve all told us that they are not going to sell to us because thats part of the deal they made with the federal government, he said. To me, thats blocking.
Manitoba government officials provided Global News with records of their outreach to the four vaccine suppliers, which show the companies rebuffing requests from provincial officials to negotiate contracts.
Story continues below advertisement
None of the responses from the vaccine companies in those emails stated that they were prohibited from entering into separate contracts with the provinces because of their federal contract.
[ Sign up for our Health IQ newsletter for the latest coronavirus updates ]
One official from the Manitoba governments procurement team appeared to paraphrase a response received from Janssen, the subsidiary of Johnson & Johnson that is developing the coronavirus vaccine.
Talked with Janssen, direction from them is they are only working with one entity per country PHAC, said the official, whose name was redacted in the records provided to Global News. They will not (sic) entertain working with us for additional vaccines once we receive volumes from Feds. They only want to engage with PHAC.
An email that appeared to come from Moderna said the company wasnt interested in separate deals.
Modernas position on this remains the same as shared on our call last Friday, said an official in the email, whose name was redacted in the records provided to Global News. We are currently fully committed to the government of Canada to bring as many doses possible to Canada in 2021.
Another email that appeared to come from an official at AstraZeneca Canadas Mississauga location offered a similar response, noting their vaccine candidate remains under review by Health Canada.
Our commitment is to fulfill the supply requested by the Federal Government post Health Canada regulatory approval, said the official, whose name was redacted in the records.
Story continues below advertisement
Unfortunately at this time we are still unable to respond to your specific provincial request.
The response that appeared to come from Pfizer was brief: The situation has not changed and contracts with individual provinces are not currently possible.
Pfizer was the only company to respond to Global News questions by deadline.
Any responses received by Moderna, AstraZeneca or Johnson & Johnson will be included once received.
Global News asked Pallisters office whether the provincial government had received any responses from the vaccine companies that specifically said the federal contracts prohibited them from selling to the provinces, as Pallister had indicated in his interview.
Olivia Billson, spokesperson for the premier, said the province is being blocked from buying vaccines from those companies if the companies are not taking orders until they fulfill the federal contracts.
Story continues below advertisement
Manitoba has reached out repeatedly to COVID-19 vaccine suppliers since late last year on our own initiative to secure a direct supply of vaccines for Manitobans, she said in an email.
Vaccine suppliers have clearly indicated to our government that they are unable to take any orders from us at this time until they fulfill federal orders. That is fact, effectively blocking us from securing vaccines on our own accord.
The federal government has not released the details of any of its contracts with the major vaccine suppliers, despite repeated urging from premiers and opposition parties to be more transparent.
Procurement Minister Anita Anand said the government is bound by confidentiality clauses in those contracts, and has been trying to get vaccine companies to loosen those terms.
So far, she said, those efforts have been unsuccessful.
2021 Global News, a division of Corus Entertainment Inc.
Read the rest here:
Heres why some coronavirus vaccine suppliers say they arent selling to provinces - Global News
- High Hopes for Johnson & Johnsons Covid Vaccine Have Fizzled in the U.S. - The New York Times - June 19th, 2021
- Coronavirus vaccination: Why do you experience a sore arm after your COVID-19 vaccination? - Times of India - June 19th, 2021
- While mRNA saved the COVID-19 day, GSK and Sanofi vaccines likely safe beyond pandemic: analysts - FiercePharma - June 19th, 2021
- As California reopens, 6 things you need to know about COVID-19 - CalMatters - June 16th, 2021
- Can Vaccinated People Transmit COVID-19 to Others? - Health Essentials from Cleveland Clinic - June 16th, 2021
- Getting vaccinated | Coronavirus Victoria - June 13th, 2021
- Coronavirus Vaccine Appointments | Allegheny Health Network - June 13th, 2021
- Pfizer, Moderna vaccines reduce infection risk by 91%; COVID-19 causes more complications in children than th - cleveland.com - June 11th, 2021
- U.S. Covid Vaccine Donations Will Go to 'Wide Range' of Nations - The New York Times - June 7th, 2021
- Well Probably Need Booster Shots for Covid-19. But When? And Which Ones? - The New York Times - June 7th, 2021
- Covid UK news live - Infection surge continues with 5,341 new cases today - The Independent - June 7th, 2021
- Are Handshakes Safe If Youve Been Vaccinated for COVID-19? - Health Essentials from Cleveland Clinic - June 7th, 2021
- Heart reaction probed as possible rare vaccine link in teens - The Associated Press - June 5th, 2021
- 70% of adults in 12 states have received at least 1 COVID vaccine dose: CDC - ABC News - June 3rd, 2021
- Covid News: New Virus Variant Races Through Britain and Poses Fresh Threat as Global Vaccination Drive Falters - The New York Times - June 3rd, 2021
- COVID-19: UK records another six coronavirus deaths as more than 25 million people receive two vaccine doses - Sky News - May 31st, 2021
- Will We Need a COVID-19 Vaccine Booster Shot? - Healthline - May 31st, 2021
- Ways to revive your skin post Covid-19 recovery - Times of India - May 31st, 2021
- Watch: What Nick Offerman told Congress about the COVID-19 vaccine - Deseret News - May 31st, 2021
- Production of another COVID-19 vaccine to begin in weeks - ABC News - May 31st, 2021
- Connecticut has seen 18 cases of heart inflammation after COVID-19 vaccination. But doctors say teens and young adults should still get the shot -... - May 27th, 2021
- Who is next on the list for Covid vaccines - and how will I be invited to book an appointment? - The Telegraph - May 27th, 2021
- CDC Will Not Investigate Mild Infections in Vaccinated Americans - The New York Times - May 26th, 2021
- The women possibly at higher risk for Covid-19 that no one is talking about - CNN - May 24th, 2021
- CDC looking at reports of heart problem in a few young vaccine recipients - Chicago Tribune - May 24th, 2021
- For Colleges, Coronavirus Vaccine Mandates Often Depend on Which Party Is in Power - The New York Times - May 24th, 2021
- Do COVID-19 vaccines care whether you're female or male? - MSUToday - May 22nd, 2021
- Covid News: New York and New Jersey Make Big Moves to Reopen - The New York Times - May 22nd, 2021
- Philippines Says People Won't Be Given A Choice Of COVID-19 Vaccine : Coronavirus Updates - NPR - May 20th, 2021
- A universal vaccine for coronavirus and some common colds? Seattle scientists are working on it - KING5.com - May 18th, 2021
- How The Covid-19 Vaccine Injected Billions Into Big PharmaAnd Made Its Executives Very Rich - Forbes - May 15th, 2021
- CDC Says Kids As Young As 12 Should Get The Pfizer COVID-19 Vaccine - NPR - May 13th, 2021
- CDC's slow, cautious Covid-19 messaging seems out of step with moment - STAT - May 12th, 2021
- The latest on Covid-19 and India's worsening crisis: Live updates - CNN International - May 8th, 2021
- When will the COVID-19 pandemic end? It depends on what people do as coronavirus restrictions ease. - News@Northeastern - May 8th, 2021
- Global PCR and Realtime PCR Testing Market Report 2021: COVID-19 Impacts, Implications and Growth Forecast to 2025 & 2030 - ResearchAndMarkets.com... - May 6th, 2021
- So coronavirus vaccines arent perfect. Theyre still very, very effective - The San Diego Union-Tribune - May 4th, 2021
- Alarm grows in Africa as it watches India's COVID-19 crisis - The Associated Press - May 4th, 2021
- Finding the Universal Coronavirus Vaccine - The Atlantic - May 2nd, 2021
- THURSDAY UPDATES: Boone County first in state with beginning and completing coronavirus vaccine with percent of population - ABC17NEWS - ABC17News.com - April 30th, 2021
- Coronavirus vaccination numbers are on the decline - KENS5.com - April 28th, 2021
- Emerging Markets Report: The Rich Get Richer - April 26th, 2021
- MediPharm Labs Expands Global Portfolio in 9 Countries Including Medical and Wellness Customers for Turnkey Manufacturing and Distribution Solutions;... - April 26th, 2021
- ContraFect Invited to Participate in the Cystic Fibrosis Target Product Profile Virtual Symposium - April 26th, 2021
- Avicanna Provides Bi-Weekly Update On Status Of Management Cease Trade Order - April 26th, 2021
- Auxly Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Outlook for 2021 - April 26th, 2021
- InMed Pharmaceuticals Achieves 2g/L Cannabinoid Yield with IntegraSyn™ - April 26th, 2021
- Mydecine to Report Full Year 2020 Financial Results on May 3, 2021 - April 26th, 2021
- Nephros Announces First Quarter 2021 Financial Results Conference Call - April 26th, 2021
- TG Therapeutics to Participate in the B. Riley Securities Neuroscience Conference - April 26th, 2021
- Rubius Therapeutics to Announce First Quarter 2021 Financial Results - April 26th, 2021
- Progenity to Present Two Abstracts for Novel Ingestible Drug Delivery Technologies at Digestive Disease Week 2021 - April 26th, 2021
- Voyager Therapeutics Receives FDA Clearance of IND Application for Gene Therapy Candidate VY-HTT01 for Treatment of Huntington’s Disease - April 26th, 2021
- Genetic Technologies’ COVID-19 Risk Test Approved for Commercial Release - April 26th, 2021
- Pacific Biosciences Launches New HiFi Sequencing Workflow to Further Improve HiFi’s Industry Leading Accuracy - April 26th, 2021
- ADMA Biologics Opens Newest ADMA BioCenters Plasma Collection Facility in Goose Creek, S.C. - April 26th, 2021
- Intercept to Announce First Quarter 2021 Financial Results on May 6, 2021 - April 26th, 2021
- Vaxart to Host a Key Opinion Leader Webinar on the Importance of T-Cell Responses for COVID-19 Vaccines - April 26th, 2021
- Akero Therapeutics Appoints Yuan Xu to its Board of Directors - April 26th, 2021
- Saniona to Present at Multiple Upcoming Investor Conferences - April 26th, 2021
- BioCardia Signs Agreement with Leading Japanese Biotechnology Company for Catheter Biotherapeutic Delivery Product Candidates - April 26th, 2021
- The benefits of J&J vaccine and birth control outweigh tiny risk of blood clots - MarketWatch - April 19th, 2021
- Coronavirus news live: Latest as lockdown easing sees shops and pubs crowded - The Independent - April 12th, 2021
- Covid UK: coronavirus cases, deaths and vaccinations today - The Guardian - April 12th, 2021
- Asia Today: India records another surge in COVID-19 cases - The Associated Press - April 12th, 2021
- The Pfizer/BioNTech Covid-19 Vaccine Is Less Effective Against The South African And UK Variants Than Against The Original Virus, According To A New... - April 12th, 2021
- How Long Should You Wait To Get the Vaccine After Having COVID-19? - ideastream - April 9th, 2021
- What you should (and shouldn't) do with your vaccination card - KING5.com - April 9th, 2021
- UC Davis Health opening vaccinations up to anyone 16 and older | COVID-19 Updates in Northern California - ABC10.com KXTV - April 7th, 2021
- Can Vaccinated People Spread the Virus? - The New York Times - April 5th, 2021
- Germany to restrict AstraZeneca use in under-60s over clots - The Associated Press - April 5th, 2021
- The COVID-19 vaccine side effects you can expect based on your age, sex, and dose - Business Insider - April 5th, 2021
- Covid-19: Johnson & Johnson Put in Charge of Plant That Ruined Millions of Vaccine Doses - The New York Times - April 5th, 2021
- Germany restricts use of AstraZeneca vaccine to over 60s in most cases - DW (English) - April 5th, 2021
- Coronavirus vaccines with a side of fried fish are on the Good Friday menu in Central City - NOLA.com - April 3rd, 2021
- Explained: Making sense of Indias Covid-19 data - The Indian Express - April 3rd, 2021
- 35 Pa. counties have substantial spread of COVID-19; positive test rate rises for second week in a row - PennLive - March 30th, 2021
- Covid-19 News: In-Person School Attendance Inches Up but Roadblocks Remain - The New York Times - March 30th, 2021
- COVID-19 cases surging in Pa. and N.J. as variants spread; Biden sets goal of 200 million vaccinations by end - The Philadelphia Inquirer - March 28th, 2021
- Why Supply Isnt the Only Thing Stymying Europes Coronavirus Vaccine Rollout - The New York Times - March 26th, 2021